(Q34750189)

4 August 2017

Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome (English)

1 reference

4 August 2017

1 reference

Asahito Hama

1

1 reference

4 August 2017

Hiroshi Yagasaki

2

1 reference

4 August 2017

Yoshiyuki Takahashi

3

1 reference

4 August 2017

Nobuhiro Nishio

4

1 reference

4 August 2017

Hideki Muramatsu

5

1 reference

4 August 2017

Nao Yoshida

6

1 reference

4 August 2017

Makito Tanaka

7

1 reference

4 August 2017

Hirokazu Hidaka

8

1 reference

4 August 2017

Nobuhiro Watanabe

9

1 reference

4 August 2017

Ayami Yoshimi

10

1 reference

4 August 2017

Kimikazu Matsumoto

11

1 reference

4 August 2017

Kazuko Kudo

12

1 reference

4 August 2017

Koji Kato

13

1 reference

4 August 2017

Keizo Horibe

14

1 reference

4 August 2017

Seiji Kojima

15

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

British Journal of Haematology

4 August 2017

1 reference

4 August 2017

140

1 reference

4 August 2017

5

1 reference

4 August 2017

552-561

1 reference

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group

4 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Acute Megakaryoblastic Leukaemia: A National Clinical and Biological Study of 53 Adult and Childhood Cases by the Groupe Français d'Hématologie Cellulaire (GFHC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Comprehensive analysis of gene alterations in acute megakaryoblastic leukemia of Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Hemophagocytosis by leukemic blasts in 7 acute myeloid leukemia cases with t(16;21)(p11;q22): common morphologic characteristics for this type of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Biology, clinical, and hematologic features of acute megakaryoblastic leukemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06971.X

10.1111/J.1365-2141.2007.06971.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference